Epithelial to mesenchymal transition (EMT) as well as its reversal process, mesenchymal to epithelial transition (MET), are essential and well-controlled cellular processes during embryonic development. Tightly controlled regulatory mechanisms guide an EMT/MET plasticity and enable cells to switch forth and back between different cell morphologies and functional capabilities to endow the necessity of tissue plasticity. However, aberrant and uncontrolled activation of these processes during malignant tumor progression promotes primary tumor cell invasion, cancer cell dissemination and metastatic outgrowth. In a recent study (Nat Commun; doi: 10.1038/s41467-017-01197-w), we have reported on the post-transcriptional control of normal and cancer-associated EMT by miRNAs and identified a novel, critical double-negative feedback regulation of the thus far unknown miRNA miR1199 and the key EMT transcription factor Zeb1.
In the context of malignant tumor progression epithelial tumor cells can gain metastatic properties via an EMT induced by diverse extracellular stimuli (e.g. transforming growth factor β, TGFβ), which enables cancer cells to invade the surrounding tissue, disseminate through the blood circulation, seed distant metastases, and also escape therapy. Such major morphological and phenotypic changes require global adaptations of a cell`s transcriptomic landscape.
MiRNAs are a class of non-coding RNAs, which can alter gene expression during an EMT on the post-transcriptional level by either promoting mRNA degradation or preventing mRNA translation. In order to identify critical miRNAs functional during normal and cancer-associated EMT/MET plasticity, we first performed miRNA-sequencing on a detailed time course of a TGFβ-induced EMT in normal murine mammary gland cells. MiRNAs displaying a strong differential regulation in transcription were further tested for their functional contribution to an EMT and to mesenchymal tumor cell migration. We identified miR-1199-5p with reduced transcriptional expression and promoter activity during a TGFβ-induced EMT in various cellular models of EMT. Forced expression of miR-1199-5p in mouse and human untransformed mammary gland cells was sufficient to block EMT, decrease mesenchmyal breast cancer cell migration and invasion in vitro and, most importantly, to reduce the number of tumor cells circulating in the blood stream of tumor-bearing mice and the formation of lung metastasis in vivo. We further have reported that miR-1199-5p is embedded in a reciprocal regulation with the EMT transcription factor Zeb1. MiR-1199-5p represses the transcript levels of Zeb1 in epithelial cells on the posttranscriptional level. Upon the induction of an EMT, Zeb1 binds to a specific E-box motif in the promoter region of the miR-1199 gene and represses its promoter activity (Figure 1) . Interestingly, the Zeb transcription factor family member Zeb2 also negatively controls the miR-1199 promoter activity to the same extent as Zeb1. However, no miR-1199-5p binding site was identified in the Zeb2 3` untranslated region (3`UTR) and we have not observed a regulation of Zeb2 mRNA by miR-1199-5p. In summary, we have reported the identification and characterization of a novel miRNA regulating an EMT by repressing the expression of the EMT transcription factor Zeb1.
Along with miR-1199-5p, we also identified in our EMT screen two well-known mediators of an epithelial cell phenotype, the miR- The gain of function approaches of miR-1199-5p and miR-200 family members clearly demonstrate that the transcriptional downregulation of these miRNAs is required for an EMT as well as mesenchymal tumor cell migration and invasion. In loss of function studies for all the individual miRNAs (miR-1199-5p, miR-200b/c-3p) , using miRNA inhibitors and miRNA sponge constructs, we failed to observe an effect on Zeb1 mRNA expression levels and overall EMT induction. Since these miRNAs operate on the same transcription factor in a reciprocal manner, we suspect that the loss of one regulator is not enough to destabilize such a "buffered system".
Regulatory feedback loops consisting of a miRNA and key EMT transcription factors which control EMT and malignant tumor progression have now been reported by many independent research groups. Such reciprocal regulations are central molecular switches which provide functional robustness and enable a tight control of cell identity and regulate the extent of cellular plasticity, for example during an EMT.
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